FDA held a meeting with several states to discuss the section 804 importation program (SIP), which allows states and Indian tribes to import certain prescription drugs from Canada to significantly reduce the cost of these drugs to the American consumer.
Similar Posts
Emerging Drug Safety Technology Meetings (EDSTM)
CDER has established a meeting program called the Emerging Drug Safety Technology Meeting (EDSTM) program. Learn more.Olympus Announces Voluntary Corrective Action for the Single-Use Ligating Device
Center Valley, Pa., (December 5, 2025)-Olympus Corporation today announced a voluntary medical device corrective action for its Single-Use Ligating Device (“Polyloop”) following identification of a potential safety issue.motionpharmacy.com – 715595 – 09/10/2025
Unapproved New Drug/MisbrandedVITAFER-L Gold 20ml may be harmful due to hidden drug ingredient
The Food and Drug Administration is advising consumers not to purchase or use VITAFER-L Gold 20ml, a product promoted for energy and sexual enhancement on various websites, including www.amazon.com.Update on the Safety of Andexxa by AstraZeneca: FDA Safety Communication
Since approval, the FDA has received postmarketing safety data on thromboembolic events, including serious and fatal outcomes, in patients treated with Andexxa (coagulation factor Xa (recombinant), inactivated-zhzo). Based on available data, the serious risks including the increase in thromboembolicPureRawz – 715218 – 09/08/2025
Unapproved New Drugs/Misbranded